Aardvark Therapeutics Inc. Common Stock

AARD | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.57

+$0.19 (+3.53%)

At close: Sep 21, 2026, 4:00 PM ET

$5.56

-$0.01 (-0.18%)

After-hours: Sep 21, 2026, 7:54 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.53%

(1D)

Rating

Updated: Aug 22, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $121.89M

1D Range

5.35 5.58

52W Range

3.35 17.94

Valuation (TTM)

PE -1.74

PB 1.63

EV/EBITDA -0.70

Valuation (NTM)

Forward PE N/A

Forward PEG 0.09

Price Target $3

Cash Flow

FCF Yield -56.9%

SBC Adj. FCF Yield -60.2%

SBC Impact -5.7%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -87.8% | N/A

FCF 3Y | 5Y -92.8% | N/A

Returns

ROA -85.8%

ROE -71.5%

ROIC -98.0%

Financial Health

Net Cash

$73.19M

Current Ratio 12.63

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's n...

Sector Healthcare

Industry Biotechnology

Employees 28

IPO Date Feb 12, 2025

Website aardvarktherapeutics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Downside

-46.14%

Buy (2)

Hold (4)

Sell (1)

Analyst Details ➞